Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.

Autor: Patil SB; Indian Council of Medical Research (ICMR) - National AIDS Research Institute, Pune, India., Tamirat M; Partners In Health, Maseru, Lesotho., Khazhidinov K; Partners In Health, Astana, Kazakhstan., Ardizzoni E; Institute of Tropical Medicine (ITM), Antwerp, Belgium., Atger M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Austin A; UCSF Center for Tuberculosis, University of California, , San Francisco, San Francisco, CA, USA., Baudin E; Epicentre, Paris, France., Bekhit M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Bektasov S; National TB Center, Almaty, Kazakhstan., Berikova E; Partners In Health, Astana, Kazakhstan.; National Scientific Center of Phthisiopulmonology, Almaty, Kazakhstan., Bonnet M; Université de Montpellier, IRD, INSERM, Montpellier, TransVIHMI, France., Caboclo R; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Chaudhry M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Chavan V; Médecins Sans Frontières, Mumbai, India., Cloez S; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Coit J; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Coutisson S; Médecins Sans Frontières, Geneva, Switzerland., Dakenova Z; City Center of Phthisiopulmonology, Astana, Kazakhstan., De Jong BC; Institute of Tropical Medicine (ITM), Antwerp, Belgium., Delifer C; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Demaisons S; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Do JM; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Dos Santos Tozzi D; Incyte, Morges, Switzerland., Ducher V; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Ferlazzo G; Médecins Sans Frontières, Geneva, Switzerland., Gouillou M; Epicentre, Paris, France., Khan U; Interactive Research and Development (IRD) Global, Singapore, Singapore., Kunda M; Partners In Health, Maseru, Lesotho., Lachenal N; Médecins Sans Frontières, Geneva, Switzerland., LaHood AN; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Lecca L; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Socios En Salud-Sucursal Peru, Lima, Peru., Mazmanian M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France.; Assistance Publique Hôpitaux de Paris (APHP), Unité de Recherche Clinique, Hôpital Pitié-Salpêtrière, Paris, France.; Santé Arménie French-Armenian Research Center, Yerevan, Armenia., McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Moreau M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Moschioni M; Medicines Patent Pool, Geneva, Switzerland., Nahid P; UCSF Center for Tuberculosis, University of California, , San Francisco, San Francisco, CA, USA., Osso E; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Oyewusi L; Partners In Health, Maseru, Lesotho., Panda S; Indian Council of Medical Research Headquarters, New Delhi, India.; Indian Journal of Medical Research, New Delhi, India., Pâquet A; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Thuong Huu P; Hanoi Lung Hospital, Hanoi, Vietnam., Pichon L; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Rich ML; Partners In Health, Boston, MA, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Rupasinghe P; Institute of Tropical Medicine (ITM), Antwerp, Belgium., Salahuddin N; Indus Hospital & Health Network, Karachi, Pakistan., Sanchez Garavito E; Hospital Nacional Sergio E. Bernales, Lima, Peru., Seung KJ; Partners In Health, Boston, MA, USA., Velásquez GE; UCSF Center for Tuberculosis, University of California, , San Francisco, San Francisco, CA, USA.; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Vallet M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Varaine F; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Yuya-Septoh FJ; Epicentre, Paris, France., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Partners In Health, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Guglielmetti L; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France. Lorenzo.GUGLIELMETTI@paris.msf.org.; Sorbonne Université, INSERM, U1135, Centre d'Immunologie Et Des Maladies Infectieuses, Paris, France. Lorenzo.GUGLIELMETTI@paris.msf.org.; Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris, France. Lorenzo.GUGLIELMETTI@paris.msf.org.

Publikováno v: Trials [Trials] 2023 Nov 30; Vol. 24 (1), pp. 773. Date of Electronic Publication: 2023 Nov 30.